Global and United States Hepatitis B and C Diagnostics Market Size, Status and Forecast 2021-2027

Global and United States Hepatitis B and C Diagnostics Market Size, Status and Forecast 2021-2027

Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Hepatitis B and C Diagnostics Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Hepatitis B
1.2.3 Hepatitis C
1.3 Market by Application
1.3.1 Global Hepatitis B and C Diagnostics Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Immunodiagnostics
1.3.3 Nucleic Acid Test (NAT)
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Hepatitis B and C Diagnostics Market Perspective (2016-2027)
2.2 Hepatitis B and C Diagnostics Growth Trends by Regions
2.2.1 Hepatitis B and C Diagnostics Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Hepatitis B and C Diagnostics Historic Market Share by Regions (2016-2021)
2.2.3 Hepatitis B and C Diagnostics Forecasted Market Size by Regions (2022-2027)
2.3 Hepatitis B and C Diagnostics Industry Dynamic
2.3.1 Hepatitis B and C Diagnostics Market Trends
2.3.2 Hepatitis B and C Diagnostics Market Drivers
2.3.3 Hepatitis B and C Diagnostics Market Challenges
2.3.4 Hepatitis B and C Diagnostics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Hepatitis B and C Diagnostics Players by Revenue
3.1.1 Global Top Hepatitis B and C Diagnostics Players by Revenue (2016-2021)
3.1.2 Global Hepatitis B and C Diagnostics Revenue Market Share by Players (2016-2021)
3.2 Global Hepatitis B and C Diagnostics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Hepatitis B and C Diagnostics Revenue
3.4 Global Hepatitis B and C Diagnostics Market Concentration Ratio
3.4.1 Global Hepatitis B and C Diagnostics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Hepatitis B and C Diagnostics Revenue in 2020
3.5 Hepatitis B and C Diagnostics Key Players Head office and Area Served
3.6 Key Players Hepatitis B and C Diagnostics Product Solution and Service
3.7 Date of Enter into Hepatitis B and C Diagnostics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Hepatitis B and C Diagnostics Breakdown Data by Type
4.1 Global Hepatitis B and C Diagnostics Historic Market Size by Type (2016-2021)
4.2 Global Hepatitis B and C Diagnostics Forecasted Market Size by Type (2022-2027)
5 Hepatitis B and C Diagnostics Breakdown Data by Application
5.1 Global Hepatitis B and C Diagnostics Historic Market Size by Application (2016-2021)
5.2 Global Hepatitis B and C Diagnostics Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Hepatitis B and C Diagnostics Market Size (2016-2027)
6.2 North America Hepatitis B and C Diagnostics Market Size by Type
6.2.1 North America Hepatitis B and C Diagnostics Market Size by Type (2016-2021)
6.2.2 North America Hepatitis B and C Diagnostics Market Size by Type (2022-2027)
6.2.3 North America Hepatitis B and C Diagnostics Market Size by Type (2016-2027)
6.3 North America Hepatitis B and C Diagnostics Market Size by Application
6.3.1 North America Hepatitis B and C Diagnostics Market Size by Application (2016-2021)
6.3.2 North America Hepatitis B and C Diagnostics Market Size by Application (2022-2027)
6.3.3 North America Hepatitis B and C Diagnostics Market Size by Application (2016-2027)
6.4 North America Hepatitis B and C Diagnostics Market Size by Country
6.4.1 North America Hepatitis B and C Diagnostics Market Size by Country (2016-2021)
6.4.2 North America Hepatitis B and C Diagnostics Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Hepatitis B and C Diagnostics Market Size (2016-2027)
7.2 Europe Hepatitis B and C Diagnostics Market Size by Type
7.2.1 Europe Hepatitis B and C Diagnostics Market Size by Type (2016-2021)
7.2.2 Europe Hepatitis B and C Diagnostics Market Size by Type (2022-2027)
7.2.3 Europe Hepatitis B and C Diagnostics Market Size by Type (2016-2027)
7.3 Europe Hepatitis B and C Diagnostics Market Size by Application
7.3.1 Europe Hepatitis B and C Diagnostics Market Size by Application (2016-2021)
7.3.2 Europe Hepatitis B and C Diagnostics Market Size by Application (2022-2027)
7.3.3 Europe Hepatitis B and C Diagnostics Market Size by Application (2016-2027)
7.4 Europe Hepatitis B and C Diagnostics Market Size by Country
7.4.1 Europe Hepatitis B and C Diagnostics Market Size by Country (2016-2021)
7.4.2 Europe Hepatitis B and C Diagnostics Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Hepatitis B and C Diagnostics Market Size (2016-2027)
8.2 Asia-Pacific Hepatitis B and C Diagnostics Market Size by Type
8.2.1 Asia-Pacific Hepatitis B and C Diagnostics Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Hepatitis B and C Diagnostics Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Hepatitis B and C Diagnostics Market Size by Type (2016-2027)
8.3 Asia-Pacific Hepatitis B and C Diagnostics Market Size by Application
8.3.1 Asia-Pacific Hepatitis B and C Diagnostics Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Hepatitis B and C Diagnostics Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Hepatitis B and C Diagnostics Market Size by Application (2016-2027)
8.4 Asia-Pacific Hepatitis B and C Diagnostics Market Size by Region
8.4.1 Asia-Pacific Hepatitis B and C Diagnostics Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Hepatitis B and C Diagnostics Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Hepatitis B and C Diagnostics Market Size (2016-2027)
9.2 Latin America Hepatitis B and C Diagnostics Market Size by Type
9.2.1 Latin America Hepatitis B and C Diagnostics Market Size by Type (2016-2021)
9.2.2 Latin America Hepatitis B and C Diagnostics Market Size by Type (2022-2027)
9.2.3 Latin America Hepatitis B and C Diagnostics Market Size by Type (2016-2027)
9.3 Latin America Hepatitis B and C Diagnostics Market Size by Application
9.3.1 Latin America Hepatitis B and C Diagnostics Market Size by Application (2016-2021)
9.3.2 Latin America Hepatitis B and C Diagnostics Market Size by Application (2022-2027)
9.3.3 Latin America Hepatitis B and C Diagnostics Market Size by Application (2016-2027)
9.4 Latin America Hepatitis B and C Diagnostics Market Size by Country
9.4.1 Latin America Hepatitis B and C Diagnostics Market Size by Country (2016-2021)
9.4.2 Latin America Hepatitis B and C Diagnostics Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Hepatitis B and C Diagnostics Market Size (2016-2027)
10.2 Middle East & Africa Hepatitis B and C Diagnostics Market Size by Type
10.2.1 Middle East & Africa Hepatitis B and C Diagnostics Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Hepatitis B and C Diagnostics Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Hepatitis B and C Diagnostics Market Size by Type (2016-2027)
10.3 Middle East & Africa Hepatitis B and C Diagnostics Market Size by Application
10.3.1 Middle East & Africa Hepatitis B and C Diagnostics Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Hepatitis B and C Diagnostics Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Hepatitis B and C Diagnostics Market Size by Application (2016-2027)
10.4 Middle East & Africa Hepatitis B and C Diagnostics Market Size by Country
10.4.1 Middle East & Africa Hepatitis B and C Diagnostics Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Hepatitis B and C Diagnostics Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Roche Diagnostics
11.1.1 Roche Diagnostics Company Details
11.1.2 Roche Diagnostics Business Overview
11.1.3 Roche Diagnostics Hepatitis B and C Diagnostics Introduction
11.1.4 Roche Diagnostics Revenue in Hepatitis B and C Diagnostics Business (2016-2021)
11.1.5 Roche Diagnostics Recent Development
11.2 Abbott
11.2.1 Abbott Company Details
11.2.2 Abbott Business Overview
11.2.3 Abbott Hepatitis B and C Diagnostics Introduction
11.2.4 Abbott Revenue in Hepatitis B and C Diagnostics Business (2016-2021)
11.2.5 Abbott Recent Development
11.3 Siemens
11.3.1 Siemens Company Details
11.3.2 Siemens Business Overview
11.3.3 Siemens Hepatitis B and C Diagnostics Introduction
11.3.4 Siemens Revenue in Hepatitis B and C Diagnostics Business (2016-2021)
11.3.5 Siemens Recent Development
11.4 Qiagen
11.4.1 Qiagen Company Details
11.4.2 Qiagen Business Overview
11.4.3 Qiagen Hepatitis B and C Diagnostics Introduction
11.4.4 Qiagen Revenue in Hepatitis B and C Diagnostics Business (2016-2021)
11.4.5 Qiagen Recent Development
11.5 Abbott
11.5.1 Abbott Company Details
11.5.2 Abbott Business Overview
11.5.3 Abbott Hepatitis B and C Diagnostics Introduction
11.5.4 Abbott Revenue in Hepatitis B and C Diagnostics Business (2016-2021)
11.5.5 Abbott Recent Development
11.6 bioMérieux
11.6.1 bioMérieux Company Details
11.6.2 bioMérieux Business Overview
11.6.3 bioMérieux Hepatitis B and C Diagnostics Introduction
11.6.4 bioMérieux Revenue in Hepatitis B and C Diagnostics Business (2016-2021)
11.6.5 bioMérieux Recent Development
11.7 Cepheid
11.7.1 Cepheid Company Details
11.7.2 Cepheid Business Overview
11.7.3 Cepheid Hepatitis B and C Diagnostics Introduction
11.7.4 Cepheid Revenue in Hepatitis B and C Diagnostics Business (2016-2021)
11.7.5 Cepheid Recent Development
11.8 Chembio Diagnostics
11.8.1 Chembio Diagnostics Company Details
11.8.2 Chembio Diagnostics Business Overview
11.8.3 Chembio Diagnostics Hepatitis B and C Diagnostics Introduction
11.8.4 Chembio Diagnostics Revenue in Hepatitis B and C Diagnostics Business (2016-2021)
11.8.5 Chembio Diagnostics Recent Development
11.9 DiaSorin
11.9.1 DiaSorin Company Details
11.9.2 DiaSorin Business Overview
11.9.3 DiaSorin Hepatitis B and C Diagnostics Introduction
11.9.4 DiaSorin Revenue in Hepatitis B and C Diagnostics Business (2016-2021)
11.9.5 DiaSorin Recent Development
11.10 Enzo Life Sciences
11.10.1 Enzo Life Sciences Company Details
11.10.2 Enzo Life Sciences Business Overview
11.10.3 Enzo Life Sciences Hepatitis B and C Diagnostics Introduction
11.10.4 Enzo Life Sciences Revenue in Hepatitis B and C Diagnostics Business (2016-2021)
11.10.5 Enzo Life Sciences Recent Development
11.11 Hologic
11.11.1 Hologic Company Details
11.11.2 Hologic Business Overview
11.11.3 Hologic Hepatitis B and C Diagnostics Introduction
11.11.4 Hologic Revenue in Hepatitis B and C Diagnostics Business (2016-2021)
11.11.5 Hologic Recent Development
11.12 MedMira
11.12.1 MedMira Company Details
11.12.2 MedMira Business Overview
11.12.3 MedMira Hepatitis B and C Diagnostics Introduction
11.12.4 MedMira Revenue in Hepatitis B and C Diagnostics Business (2016-2021)
11.12.5 MedMira Recent Development
11.13 OraSure Technologies
11.13.1 OraSure Technologies Company Details
11.13.2 OraSure Technologies Business Overview
11.13.3 OraSure Technologies Hepatitis B and C Diagnostics Introduction
11.13.4 OraSure Technologies Revenue in Hepatitis B and C Diagnostics Business (2016-2021)
11.13.5 OraSure Technologies Recent Development
11.14 Quest Diagnostics
11.14.1 Quest Diagnostics Company Details
11.14.2 Quest Diagnostics Business Overview
11.14.3 Quest Diagnostics Hepatitis B and C Diagnostics Introduction
11.14.4 Quest Diagnostics Revenue in Hepatitis B and C Diagnostics Business (2016-2021)
11.14.5 Quest Diagnostics Recent Development
11.15 Quidel Corp
11.15.1 Quidel Corp Company Details
11.15.2 Quidel Corp Business Overview
11.15.3 Quidel Corp Hepatitis B and C Diagnostics Introduction
11.15.4 Quidel Corp Revenue in Hepatitis B and C Diagnostics Business (2016-2021)
11.15.5 Quidel Corp Recent Development
11.16 Randox Laboratories
11.16.1 Randox Laboratories Company Details
11.16.2 Randox Laboratories Business Overview
11.16.3 Randox Laboratories Hepatitis B and C Diagnostics Introduction
11.16.4 Randox Laboratories Revenue in Hepatitis B and C Diagnostics Business (2016-2021)
11.16.5 Randox Laboratories Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Hepatitis B and C Diagnostics Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Hepatitis B
Table 3. Key Players of Hepatitis C
Table 4. Global Hepatitis B and C Diagnostics Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global Hepatitis B and C Diagnostics Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Hepatitis B and C Diagnostics Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global Hepatitis B and C Diagnostics Market Share by Regions (2016-2021)
Table 8. Global Hepatitis B and C Diagnostics Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global Hepatitis B and C Diagnostics Market Share by Regions (2022-2027)
Table 10. Hepatitis B and C Diagnostics Market Trends
Table 11. Hepatitis B and C Diagnostics Market Drivers
Table 12. Hepatitis B and C Diagnostics Market Challenges
Table 13. Hepatitis B and C Diagnostics Market Restraints
Table 14. Global Hepatitis B and C Diagnostics Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global Hepatitis B and C Diagnostics Market Share by Players (2016-2021)
Table 16. Global Top Hepatitis B and C Diagnostics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Hepatitis B and C Diagnostics as of 2020)
Table 17. Ranking of Global Top Hepatitis B and C Diagnostics Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by Hepatitis B and C Diagnostics Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Hepatitis B and C Diagnostics Product Solution and Service
Table 21. Date of Enter into Hepatitis B and C Diagnostics Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Hepatitis B and C Diagnostics Market Size by Type (2016-2021) (US$ Million)
Table 24. Global Hepatitis B and C Diagnostics Revenue Market Share by Type (2016-2021)
Table 25. Global Hepatitis B and C Diagnostics Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global Hepatitis B and C Diagnostics Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global Hepatitis B and C Diagnostics Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global Hepatitis B and C Diagnostics Revenue Market Share by Application (2016-2021)
Table 29. Global Hepatitis B and C Diagnostics Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global Hepatitis B and C Diagnostics Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America Hepatitis B and C Diagnostics Market Size by Type (2016-2021) (US$ Million)
Table 32. North America Hepatitis B and C Diagnostics Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America Hepatitis B and C Diagnostics Market Size by Application (2016-2021) (US$ Million)
Table 34. North America Hepatitis B and C Diagnostics Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America Hepatitis B and C Diagnostics Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America Hepatitis B and C Diagnostics Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe Hepatitis B and C Diagnostics Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe Hepatitis B and C Diagnostics Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe Hepatitis B and C Diagnostics Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe Hepatitis B and C Diagnostics Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe Hepatitis B and C Diagnostics Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe Hepatitis B and C Diagnostics Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific Hepatitis B and C Diagnostics Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific Hepatitis B and C Diagnostics Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Hepatitis B and C Diagnostics Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific Hepatitis B and C Diagnostics Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Hepatitis B and C Diagnostics Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific Hepatitis B and C Diagnostics Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America Hepatitis B and C Diagnostics Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America Hepatitis B and C Diagnostics Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America Hepatitis B and C Diagnostics Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America Hepatitis B and C Diagnostics Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America Hepatitis B and C Diagnostics Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America Hepatitis B and C Diagnostics Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa Hepatitis B and C Diagnostics Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa Hepatitis B and C Diagnostics Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Hepatitis B and C Diagnostics Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa Hepatitis B and C Diagnostics Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Hepatitis B and C Diagnostics Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa Hepatitis B and C Diagnostics Market Size by Country (2022-2027) & (US$ Million)
Table 61. Roche Diagnostics Company Details
Table 62. Roche Diagnostics Business Overview
Table 63. Roche Diagnostics Hepatitis B and C Diagnostics Product
Table 64. Roche Diagnostics Revenue in Hepatitis B and C Diagnostics Business (2016-2021) & (US$ Million)
Table 65. Roche Diagnostics Recent Development
Table 66. Abbott Company Details
Table 67. Abbott Business Overview
Table 68. Abbott Hepatitis B and C Diagnostics Product
Table 69. Abbott Revenue in Hepatitis B and C Diagnostics Business (2016-2021) & (US$ Million)
Table 70. Abbott Recent Development
Table 71. Siemens Company Details
Table 72. Siemens Business Overview
Table 73. Siemens Hepatitis B and C Diagnostics Product
Table 74. Siemens Revenue in Hepatitis B and C Diagnostics Business (2016-2021) & (US$ Million)
Table 75. Siemens Recent Development
Table 76. Qiagen Company Details
Table 77. Qiagen Business Overview
Table 78. Qiagen Hepatitis B and C Diagnostics Product
Table 79. Qiagen Revenue in Hepatitis B and C Diagnostics Business (2016-2021) & (US$ Million)
Table 80. Qiagen Recent Development
Table 81. Abbott Company Details
Table 82. Abbott Business Overview
Table 83. Abbott Hepatitis B and C Diagnostics Product
Table 84. Abbott Revenue in Hepatitis B and C Diagnostics Business (2016-2021) & (US$ Million)
Table 85. Abbott Recent Development
Table 86. bioMérieux Company Details
Table 87. bioMérieux Business Overview
Table 88. bioMérieux Hepatitis B and C Diagnostics Product
Table 89. bioMérieux Revenue in Hepatitis B and C Diagnostics Business (2016-2021) & (US$ Million)
Table 90. bioMérieux Recent Development
Table 91. Cepheid Company Details
Table 92. Cepheid Business Overview
Table 93. Cepheid Hepatitis B and C Diagnostics Product
Table 94. Cepheid Revenue in Hepatitis B and C Diagnostics Business (2016-2021) & (US$ Million)
Table 95. Cepheid Recent Development
Table 96. Chembio Diagnostics Company Details
Table 97. Chembio Diagnostics Business Overview
Table 98. Chembio Diagnostics Revenue in Hepatitis B and C Diagnostics Business (2016-2021) & (US$ Million)
Table 99. Chembio Diagnostics Recent Development
Table 100. DiaSorin Company Details
Table 101. DiaSorin Business Overview
Table 102. DiaSorin Hepatitis B and C Diagnostics Product
Table 103. DiaSorin Revenue in Hepatitis B and C Diagnostics Business (2016-2021) & (US$ Million)
Table 104. DiaSorin Recent Development
Table 105. Enzo Life Sciences Company Details
Table 106. Enzo Life Sciences Business Overview
Table 107. Enzo Life Sciences Hepatitis B and C Diagnostics Product
Table 108. Enzo Life Sciences Revenue in Hepatitis B and C Diagnostics Business (2016-2021) & (US$ Million)
Table 109. Enzo Life Sciences Recent Development
Table 110. Hologic Company Details
Table 111. Hologic Business Overview
Table 112. Hologic Hepatitis B and C Diagnostics Product
Table 113. Hologic Revenue in Hepatitis B and C Diagnostics Business (2016-2021) & (US$ Million)
Table 114. Hologic Recent Development
Table 115. MedMira Company Details
Table 116. MedMira Business Overview
Table 117. MedMira Hepatitis B and C Diagnostics Product
Table 118. MedMira Revenue in Hepatitis B and C Diagnostics Business (2016-2021) & (US$ Million)
Table 119. MedMira Recent Development
Table 120. OraSure Technologies Company Details
Table 121. OraSure Technologies Business Overview
Table 122. OraSure Technologies Hepatitis B and C Diagnostics Product
Table 123. OraSure Technologies Revenue in Hepatitis B and C Diagnostics Business (2016-2021) & (US$ Million)
Table 124. OraSure Technologies Recent Development
Table 125. Quest Diagnostics Company Details
Table 126. Quest Diagnostics Business Overview
Table 127. Quest Diagnostics Hepatitis B and C Diagnostics Product
Table 128. Quest Diagnostics Revenue in Hepatitis B and C Diagnostics Business (2016-2021) & (US$ Million)
Table 129. Quest Diagnostics Recent Development
Table 130. Quidel Corp Company Details
Table 131. Quidel Corp Business Overview
Table 132. Quidel Corp Hepatitis B and C Diagnostics Product
Table 133. Quidel Corp Revenue in Hepatitis B and C Diagnostics Business (2016-2021) & (US$ Million)
Table 134. Quidel Corp Recent Development
Table 135. Randox Laboratories Company Details
Table 136. Randox Laboratories Business Overview
Table 137. Randox Laboratories Hepatitis B and C Diagnostics Product
Table 138. Randox Laboratories Revenue in Hepatitis B and C Diagnostics Business (2016-2021) & (US$ Million)
Table 139. Randox Laboratories Recent Development
Table 140. Research Programs/Design for This Report
Table 141. Key Data Information from Secondary Sources
Table 142. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Hepatitis B and C Diagnostics Market Share by Type: 2020 VS 2027
Figure 2. Hepatitis B Features
Figure 3. Hepatitis C Features
Figure 4. Global Hepatitis B and C Diagnostics Market Share by Application: 2020 VS 2027
Figure 5. Immunodiagnostics Case Studies
Figure 6. Nucleic Acid Test (NAT) Case Studies
Figure 7. Hepatitis B and C Diagnostics Report Years Considered
Figure 8. Global Hepatitis B and C Diagnostics Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 9. Global Hepatitis B and C Diagnostics Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 10. Global Hepatitis B and C Diagnostics Market Share by Regions: 2020 VS 2027
Figure 11. Global Hepatitis B and C Diagnostics Market Share by Regions (2022-2027)
Figure 12. Global Hepatitis B and C Diagnostics Market Share by Players in 2020
Figure 13. Global Top Hepatitis B and C Diagnostics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Hepatitis B and C Diagnostics as of 2020
Figure 14. The Top 10 and 5 Players Market Share by Hepatitis B and C Diagnostics Revenue in 2020
Figure 15. Global Hepatitis B and C Diagnostics Revenue Market Share by Type (2016-2021)
Figure 16. Global Hepatitis B and C Diagnostics Revenue Market Share by Type (2022-2027)
Figure 17. North America Hepatitis B and C Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 18. North America Hepatitis B and C Diagnostics Market Share by Type (2016-2027)
Figure 19. North America Hepatitis B and C Diagnostics Market Share by Application (2016-2027)
Figure 20. North America Hepatitis B and C Diagnostics Market Share by Country (2016-2027)
Figure 21. United States Hepatitis B and C Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 22. Canada Hepatitis B and C Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. Europe Hepatitis B and C Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Europe Hepatitis B and C Diagnostics Market Share by Type (2016-2027)
Figure 25. Europe Hepatitis B and C Diagnostics Market Share by Application (2016-2027)
Figure 26. Europe Hepatitis B and C Diagnostics Market Share by Country (2016-2027)
Figure 27. Germany Hepatitis B and C Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. France Hepatitis B and C Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. U.K. Hepatitis B and C Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. Italy Hepatitis B and C Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Russia Hepatitis B and C Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Nordic Hepatitis B and C Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Asia-Pacific Hepatitis B and C Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Asia-Pacific Hepatitis B and C Diagnostics Market Share by Type (2016-2027)
Figure 35. Asia-Pacific Hepatitis B and C Diagnostics Market Share by Application (2016-2027)
Figure 36. Asia-Pacific Hepatitis B and C Diagnostics Market Share by Region (2016-2027)
Figure 37. China Hepatitis B and C Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Japan Hepatitis B and C Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. South Korea Hepatitis B and C Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Southeast Asia Hepatitis B and C Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. India Hepatitis B and C Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Australia Hepatitis B and C Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Latin America Hepatitis B and C Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Latin America Hepatitis B and C Diagnostics Market Share by Type (2016-2027)
Figure 45. Latin America Hepatitis B and C Diagnostics Market Share by Application (2016-2027)
Figure 46. Latin America Hepatitis B and C Diagnostics Market Share by Country (2016-2027)
Figure 47. Mexico Hepatitis B and C Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Brazil Hepatitis B and C Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Middle East & Africa Hepatitis B and C Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Middle East & Africa Hepatitis B and C Diagnostics Market Share by Type (2016-2027)
Figure 51. Middle East & Africa Hepatitis B and C Diagnostics Market Share by Application (2016-2027)
Figure 52. Middle East & Africa Hepatitis B and C Diagnostics Market Share by Country (2016-2027)
Figure 53. Turkey Hepatitis B and C Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Saudi Arabia Hepatitis B and C Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. UAE Hepatitis B and C Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Roche Diagnostics Revenue Growth Rate in Hepatitis B and C Diagnostics Business (2016-2021)
Figure 57. Abbott Revenue Growth Rate in Hepatitis B and C Diagnostics Business (2016-2021)
Figure 58. Siemens Revenue Growth Rate in Hepatitis B and C Diagnostics Business (2016-2021)
Figure 59. Qiagen Revenue Growth Rate in Hepatitis B and C Diagnostics Business (2016-2021)
Figure 60. Abbott Revenue Growth Rate in Hepatitis B and C Diagnostics Business (2016-2021)
Figure 61. bioMérieux Revenue Growth Rate in Hepatitis B and C Diagnostics Business (2016-2021)
Figure 62. Cepheid Revenue Growth Rate in Hepatitis B and C Diagnostics Business (2016-2021)
Figure 63. Chembio Diagnostics Revenue Growth Rate in Hepatitis B and C Diagnostics Business (2016-2021)
Figure 64. DiaSorin Revenue Growth Rate in Hepatitis B and C Diagnostics Business (2016-2021)
Figure 65. Enzo Life Sciences Revenue Growth Rate in Hepatitis B and C Diagnostics Business (2016-2021)
Figure 66. Hologic Revenue Growth Rate in Hepatitis B and C Diagnostics Business (2016-2021)
Figure 67. MedMira Revenue Growth Rate in Hepatitis B and C Diagnostics Business (2016-2021)
Figure 68. OraSure Technologies Revenue Growth Rate in Hepatitis B and C Diagnostics Business (2016-2021)
Figure 69. Quest Diagnostics Revenue Growth Rate in Hepatitis B and C Diagnostics Business (2016-2021)
Figure 70. Quidel Corp Revenue Growth Rate in Hepatitis B and C Diagnostics Business (2016-2021)
Figure 71. Randox Laboratories Revenue Growth Rate in Hepatitis B and C Diagnostics Business (2016-2021)
Figure 72. Bottom-up and Top-down Approaches for This Report
Figure 73. Data Triangulation
Figure 74. Key Executives Interviewed

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Nuclear Medicine Cyclotron Systems Market Report, History and Forecast 2018-2029

Published: 11-Jan-2024        Price: US 3350 Onwards        Pages: 118

The global Nuclear Medicine Cyclotron Systems market was valued at US$ 220.85 million in 2022 and will reach US$ 283.75 million by the end of 2029, growing at a CAGR of 4.38% during 2023-2029. Asia-Pacific market for Nuclear Medicine Cyclotron Systems was valued at $ 61.16 million in 2022 and will reach $ 104.22 million by 2029, at a CAGR of 5.84% during the forecast period of 2023 through 2029. Report Scope This report aims to provide a comprehensive presentation of the glo......

Global Non-imaging Diagnostic Catheter Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 95

The global Non-imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......

Global Imaging Diagnostic Catheter Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 90

The global Imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated......

Global PCR Equipment Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 77

The global PCR Equipment market was valued at US$ 806 million in 2023 and is anticipated to reach US$ 1230.7 million by 2030, witnessing a CAGR of 6.7% during The forecast period 2024-2030. PCR (Polymerase Chain Reaction) equipment is widely used in molecular biology and genetics research for amplifying DNA and RNA sequences. The market for PCR equipment is influenced by several key drivers. Here are some of The significant market drivers: Advancements in Research and Diagnost......

Global Disposable Sterile Syringes and Needles Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 109

The global Disposable Sterile Syringes and Needles market was valued at US$ 404.4 million in 2023 and is anticipated to reach US$ 539.1 million by 2030, witnessing a CAGR of 2.1% during The forecast period 2024-2030. North American market for Disposable Sterile Syringes and Needles is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Disposable Sterile Syringes and N......

Global Orthopaedic Power Tools Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106

The global Orthopaedic Power Tools market was valued at US$ 463.3 million in 2023 and is anticipated to reach US$ 746.5 million by 2030, witnessing a CAGR of 7.3% during The forecast period 2024-2030. North American market for Orthopaedic Power Tools is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Orthopaedic Power Tools is estimated to increase from $ million i......

Global Cerebrospinal Fluid Management Devices Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Cerebrospinal Fluid Management Devices market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Cerebrospinal Fluid Management Devices is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Cerebrospinal Fluid Management Devices is estimate......

Global CAD & CAM Milling Burs Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 79

The global CAD & CAM Milling Burs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ ......

Global Artificial Teeth Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 98

The global Artificial Teeth market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, a......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs